SCHEMBL8934532

SCHEMBL8934532

Cc1ccc2oc(=O)c(Cc3ccccc3)c(O)c2c1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 12/20 0.79
KDM4E B2RXH2 2/20 0.57
ALDH1A1 P00352 2/20 0.57
GLA P06280 1/20 0.57
GAA P10253 1/20 0.57
HSD17B3 P37058 1/20 0.57
NPSR1 Q6W5P4 1/20 0.57
ERAP1 Q9NZ08 1/20 0.57
VKORC1 Q9BQB6 6/20 0.56
MEN1 O00255 1/20 0.56
ABCB11 O95342 1/20 0.56
LMNA P02545 1/20 0.56
TP53 P04637 1/20 0.56
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2C9 P11712 1/20 0.56
TSHR P16473 1/20 0.56
MAPK1 P28482 1/20 0.56
CYP2C19 P33261 1/20 0.56
KMT2A Q03164 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1648186 0.83 NQO1 (1.00) NQO1ALDH1A1VKORC1MEN1ABCB11
SCHEMBL14169918 0.80 NQO1 (0.78) NQO1KDM4EALDH1A1MEN1ABCB11
SCHEMBL7811513 0.79 NQO1 (0.76) NQO1KDM4EALDH1A1HSD17B3MEN1
SCHEMBL8945418 0.79 NQO1 (0.62) NQO1KDM4EALDH1A1VKORC1MEN1
SCHEMBL9208386 0.76 NQO1 (0.56) NQO1KDM4EALDH1A1GLAGAA
SCHEMBL11480049 0.76 MAOB (0.71) NQO1KDM4EALDH1A1ERAP1MEN1
SCHEMBL9211697 0.75 NQO1 (0.54) NQO1KDM4EALDH1A1GLAGAA
SCHEMBL1648127 0.74 NQO1 (0.83) NQO1ALDH1A1VKORC1MEN1ABCB11
SCHEMBL8934515 0.74 NQO1 (0.64) NQO1KDM4EALDH1A1GLAGAA
SCHEMBL7797770 0.74 KDM4E (0.74) NQO1KDM4EALDH1A1GLAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996031206-A2 FLAVONES AND COUMARINS AS AGENTS FOR THE TREATMENT OF ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-10-10 WO claimed
WO-1996031206-A2 FLAVONES AND COUMARINS AS AGENTS FOR THE TREATMENT OF ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-10-10 WO disclosed